The role of chemokines in the recruitment of lymphocytes to the liver

Digestive Diseases

Volumn 28, Issue 1, 2010, Pages 31-44

  Oo, Ye H ^a,b   Shetty, Shishir ^a,b   Adams, David H ^a,b  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

^b QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

Chemokines; Hepatic inflammation; Leukocytes

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR9; CHEMOKINE RECEPTOR CXCR3; CHEMOKINE RECEPTOR CXCR6; CXCL11 CHEMOKINE; CXCL16 CHEMOKINE; CXCL9 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; RANTES;

CELLULAR DISTRIBUTION; EFFECTOR CELL; HEPATITIS; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; LEUKOCYTE MIGRATION; LIVER DISEASE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE MIGRATION; NONHUMAN; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH17 CELL; TH2 CELL;

ANIMALS; CELL MOVEMENT; CHEMOKINES; HEPATITIS; HUMANS; LIVER; LYMPHOCYTES; RECEPTORS, CHEMOKINE; T-LYMPHOCYTES, REGULATORY;

EID: 77952566640     PISSN: 02572753     EISSN: None     Source Type: Journal    
DOI: 10.1159/000282062     Document Type: Review

References (131)

1. von Andrian UH, Mackay CR: T-cell function and migration. Two sides of the same coin. N Engl J Med 2000;343:1020-1034.
2. Heydtmann M, Adams DH: Understanding selective trafficking of lymphocyte subsets. Gut 2002;50:150-152.
3. Rot A, von Andrian UH: Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu Rev Immunol 2004;22:891-928.
4. Zlotnik A, Yoshie O: Chemokines: a new classification system and their role in immunity. Immunity 2000;12:121-127.
5. Moser B, Loetscher P: Lymphocyte traffic control by chemokines. Nat Immunol 2001;2:123-128.
6. Mellado M, Rodriguez-Frade JM, Mañes S, Mart)nez-A C: Chemokine signaling and functional responses: the role of receptor dimerization and TK pathway activation. Annu Rev Immunol 2001;19:397-421.
7. Goldman DW, Chang FH, Gifford LA, Goetzl EJ, Bourne HR: Pertussis toxin inhibition of chemotactic factor-induced calcium mobilization and function in human polymorphonuclear leukocytes. J Exp Med 1985;162:145-156.
8. Ebert LM, Schaerli P, Moser B: Chemokine-mediated control of T cell traffic in lymphoid and peripheral tissues. Mol Immunol 2005;42:799-809.
9. Schreiber TH, Shinder V, Cain DW, Alon R, Sackstein R: Shear flow-dependent integration of apical and subendothelial chemokines in T-cell transmigration: implications for locomotion and the multistep paradigm. Blood 2007;109:1381-1386.
10. Ley K, Laudanna C, Cybulsky MI, Nourshargh S: Getting to the site ofinf lammation: the leukocyte adhesion cascade updated. Nat Rev Immunol 2007;7:678-689.
11. Wong J, Johnston B, Lee SS, et al: A minimal role for selectins in the recruitment of leukocytes into the inflamed liver microvasculature. J Clin Invest 1997;99:2782-2790.
12. Adams DH, Hubscher SG, Fisher NC, Williams A, Robinson M: Expression of E-selectin and E-selectin ligands in human liver inf la mmation. Hepatology 1996;24:533-538.
13. Tanaka Y, Adams DH, Hubscher S, Hirano H, Siebenlist U, Shaw S: T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1 beta. Nature 1993;361:79-82.
14. Yadav R, Larbi KY, Young RE, Nourshargh S: Migration of leukocytes through the vessel wall and beyond. Thromb Haemost 2003;90:598-606.
15. Lee WY, Kubes P: Leukocyte adhesion in the liver: distinct adhesion paradigm from other organs. J Hepatol 2008;48:504-512.
16. Woolf E, Grigorova I, Sagiv A, et al: Lymph node chemokines promote sustained T lymphocyte motility without triggering stable integrin adhesiveness in the absence of shear forces. Nat Immunol 2007;8:1076-1085.
17. Lammermann T, Bader BL, Monkley SJ, et al: Rapid leukocyte migration by integrin-independent flowing and squeezing. Nature 2008;453:51-55.
18. Middleton J, Neil S, Wintle J, et al: Transcytosis and surface presentation of IL-8 by venular endothelial cells. Cell 1997;91:385-395.
19. McCaughan GW, Gorrell MD, Bishop GA, et al: Molecular pathogenesis of liver disease: an approach to hepatic inflammation, cirrhosis and liver transplant tolerance. Immunol Rev 2000;174:172-191.
20. Nibbs R, Graham G, Rot A: Chemokines on the move: control by the chemokine 'interceptors' Duffy blood group antigen and D6. Semin Immunol 2003;15:287-294.
21. Colditz IG, Schneider MA, Pruenster M, Rot A: Chemokines at large: in-vivo mechanisms of their transport, presentation and clearance. Thromb Haemost 2007;97:688-693.
22. Crispe IN: The liver as a lymphoid organ. Annu Rev Immunol 2009;27:147-163.
23. Knolle PA, Gerken G: Local control of the immune response in the liver. Immunol Rev 2000;174:21-34.
24. Eksteen B, Afford SC, Wigmore SJ, Holt AP, Adams DH: Immune-mediated liver injury. Semin Liver Dis 2007;27:351-366.
25. Cua DJ, Sherlock J, Chen Y, et al: Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 2003;421:744-748.
26. Stockinger B, Veldhoen M, Martin B: Th17 T cells: linking innate and adaptive immunity. Semin Immunol 2007;19:353-361.
27. Bettelli E, Carrier Y, Gao W, et al: Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006;441:235-238.
28. O'Garra A, Stockinger B, Veldhoen M: Differentiation of human T(H)-17 cells does require TGF-beta! Nat Immunol 2008;9:588-590.
29. Harrington LE, Mangan PR, Weaver CT: Expanding the effector CD4 T-cell repertoire: the Th17 lineage. Curr Opin Immunol 2006;18:349-356.
30. Langrish CL, Chen Y, Blumenschein WM, et al: IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 2005;201:233-240.
31. Annunziato F, Cosmi L, Santarlasci V, et al: Phenotypic and functional features of human Th17 cells. J Exp Med 2007;204:1849-1861.
32. Lan RY, Salunga TL, Tsuneyama K, et al: Hepatic IL-17 responses in human and murine primary biliary cirrhosis. J Autoimmun 2009;32:43-51.
33. Lemmers A, Moreno C, Gustot T, et al: The interleukin-17 pathway is involved in human alcoholic liver disease. Hepatology 2009;49:646-657.
34. Yasumi Y, Takikawa Y, Endo R, Suzuki K: Interleukin-17 as a new marker of severity of acute hepatic injur y. Hepatol Res 2007;37:248-254.
35. Zenewicz LA, Yancopoulos GD, Valenzuela DM, Murphy AJ, Karow M, Flavell RA: Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation. Immunity 2007;27:647-659.
36. Zhang JY, Zhang Z, Lin F, et al: Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B. Hepatology 2010;51:81-91.
37. Brand S, Dambacher J, Beigel F, et al: IL-22-mediated liver cell regeneration is abrogated by SOCS-1/3 overexpression in vitro. Am J Physiol Gastrointest Liver Physiol 2007;292:G1019-G1028.
38. Kimura A, Naka T, Nohara K, Fujii-Kuriyama Y, Kishimoto T: Arylhydrocarbon receptor regulates Stat1 activation and participates in the development of Th17 cells. Proc Natl Acad Sci USA 2008;105:9721-9726.
39. Veldhoen M, Hirota K, Christensen J, O'Garra A, Stockinger B: Natural agonists for aryl hydrocarbon receptor in culture medium are essential for optimal differentiation of Th17 T cells. J Exp Med 2009;206:43-49.
40. Nguyen LP, Bradfield CA: The search for endogenous activators of the aryl hydrocarbon receptor. Chem Res Toxicol 2008;21:102-116.
41. Northfield JW, Kasprowicz V, Lucas M, Klenerman P, et al: CD161 expression on hepatitis C virus-specific CD8+ T cells suggests a distinct pathway of T cell differentiation. Hepatology 2008;47:396-406.
42. Annunziato F, Cosmi L, Liotta F, Maggi E, Romagnani S: The phenotype of human Th17 cells and their precursors, the cytokines that mediate their differentiation and the role of Th17 cells in inflammation. Int Immunol 2008;20:1361-1368.
43. Hirota K, Yoshitomi H, Hashimoto M, et al: Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. J Exp Med 2007;204:2803-2812.
44. Singh SP, Zhang HH, Foley JF, Hedrick MN, Farber JM: Human T cells that are able to produce IL-17 express the chemokine receptor CCR6. J Immunol 2008;180:214-221.
45. Nistala K, Moncrieffe H, Newton KR, Varsani H, Hunter P, Wedderburn LR: Interleukin-17-producing T cells are enriched in the joints of children with arthritis, but have a reciprocal relationship to regulatory T cell numbers. Arthritis Rheum 2008;58:875-887.
46. Adams DH, Eksteen B: Aberrant homing of mucosal T cells and extra-intestinal manifestations ofinflammatory bowel disease. Nat Rev Immunol 2006;6:244-251.
47. Eksteen B, Miles AE, Grant AJ, Adams DH: Lymphocyte homing in the pathogenesis of extra-intestinal manifestations ofinflammatory bowel disease. Clin Med 2004;4:173-180.
48. Lalor PF, Adams DH: Adhesion of lymphocytes to hepatic endothelium. Mol Pathol 1999;52:214-219.
49. Valiante NM, D'Andrea A, Crotta S, et al: Life, activation and death ofintrahepatic lymphocytes in chronic hepatitis C. Immunol Rev 2000;174:77-89.
50. Napol i J, Bishop GA, McGuin ness PH, Painter DM, McCaughan GW: Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines. Hepatology 1996;24:759-765.
51. Shields PL, Morland CM, Salmon M, Qin S, Hubscher SG, Adams DH: Chemokine and chemokine receptor interactions provide a mechanism for selective T cell recruitment to specific liver compartments within hepatitis C-infected liver. J Immunol 1999;163:6236-6243.
52. Bertoletti A, D'Elios MM, Boni C, et al: Different cytokine profiles ofintraphepatic T cells in chronic hepatitis B and hepatitis C virus infections. Gastroenterology 1997;112:193-199,
53. comment by Woitas KR, Sauerbruch T, Spengler H in Gastroenterology 1997;113:1050-1051.
54. Kunkel EJ, Boisvert J, Murphy K, et al: Expression of the chemokine receptors CCR4, CCR5, and CXCR3 by human tissue-infiltrating lymphocytes. Am J Pathol 2002;160:347-355.
55. Heydtmann M, Hardie D, Shields PL, et al: Detailed analysis ofintrahepatic CD8 T cells in the normal and hepatitis C-infected liver reveals differences in specific populations of memory cells with distinct homing phenotypes. J Immunol 2006;177:729-738.
56. Boisvert J, Kunkel EJ, Campbell JJ, Keeffe EB, Butcher EC, Greenberg HB: Liver-infiltrating lymphocytes in end-stage hepatitis C virus: subsets, activation status, and chemokine receptor phenotypes. J Hepatol 2003;38:67-75.
57. Leroy V, Vigan I, Mosnier JF, et al: Phenotypic and functional characterization of intrahepatic T lymphocytes during chronic hepatitis C. Hepatology 2003;38:829-841.
58. Murai M, Yoneyama H, Harada A, et al: Active participation of CCR5(+)CD8(+) T lymphocytes in the pathogenesis of liver injury in graft-versus-host disease. J Clin Invest 1999;104:49-57.
59. Ajuebor MN, Hogaboam CM, Le T, Proud-foot AE, Swain MG: CCL3/MIP-1alpha is pro-inflammatory in murine T cell-mediated hepatitis by recruiting CCR1-expressing CD4(+) T cells to the liver. Eur J Immunol 2004;34:2907-2918.
60. Harvey CE, Post JJ, Palladinetti P, et al: Expression of the chemokine IP-10 (CXCL10) by hepatocytes in chronic hepatitis C virus infection correlates with histological severity and lobular inflammation. J Leukoc Biol 2003;74:360-369.
61. Curbishley SM, Eksteen B, Gladue RP, Lalor P, Adams DH: CXCR3 activation promotes lymphocyte transendothelial migration across human hepatic endothelium under fluid flow. Am J Pathol 2005;167:887-899.
62. Arai K, Liu ZX, Lane T, Dennert G: IP-10 and Mig facilitate accumulation of T cells in the virus-infected liver. Cell Immunol 2002;219:48-56.
63. Dumoulin FL, Bach A, Leifeld L, et al: Semi-quantitative analysis ofintrahepatic cytokines mRNA in chronic hepatitis C. J Infect Dis 1997;175:681-685.
64. Diago M, Castellano G, Garcia-Samaniego J, et al: Association of pretreatment serum in-terferon gamma inducible protein 10 levels with sustained virological response to pegin-terferon plus ribavirin therapy in genotype 1 infected patients with chronic hepatitis C. Gut 2006;55:374-379.
65. Apolinario A, Majano PL, Alvarez-Perez E, et al: Increased expression of T cell chemokines and their receptors in chronic hepatitis C: relationship with the histological activity of liver disease. Am J Gastroenterol 2002;97:2861-2870.
66. Larrubia JR, Calvino M, Benito S, et al: The role of CCR5/CXCR3 expressing CD8+ cells in liver damage and viral control during persistent hepatitis C virus infection. J Hepatol 2007;47:632-641.
67. Butera D, Marukian S, Iwamaye AE, et al: Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C. Blood 2005;106:1175-1182.
68. Nishioji K, Okanoue T, Itoh Y, et al: Increase of chemokine interferon-inducible protein-10 (IP-10) in the serum of patients with autoimmune liver diseases and increase ofits mRNA expression in hepatocytes. Clin Exp Immunol 2001;123:271-279.
69. Helbig KJ, Ruszkiewicz A, Semendric L, Harley HA, McColl SR, Beard MR: Expression of the CXCR3 ligand I-TAC by hepatocytes in chronic hepatitis C and its correlation with hepatic inflammation. Hepatology 2004;39:1220-1229.
70. Cruise MW, Lukens JR, Nguyen AP, Lassen MG, Waggoner SN, Hahn YS: Fas ligand is responsible for CXCR3 chemokine induction in CD4+ T cell-dependent liver damage. J Immunol 2006;176:6235-6244.
71. Eksteen B, Grant AJ, Miles A, et al: Hepatic endothelial CCL25 mediates the recruitment of CCR9+ gut-homing lymphocytes to the liver in primary sclerosing cholangitis. J Exp Med 2004;200:1511-1517.
72. Middleton J, Patterson AM, Gardner L, Schmutz C, Ashton BA: Leukocyte extravasation: chemokine transport and presentation by the endothelium. Blood 2002;100:3853-3860.
73. Shiratori Y, Takada H, Hikiba Y, et al: Production of chemotactic factor, interleukin-8, from hepatocytes exposed to ethanol. Hepatology 1993;18:1477-1482.
74. Morland CM, Fear J, McNab G, Joplin R, Adams DH: Promotion of leukocyte transendothelial cell migration by chemokines derived from human biliary epithelial cells in vitro. Proc Assoc Am Physicians 1997;109:372-382.
75. Maher JJ: Rat hepatocytes and Kupffer cells interact to produce interleukin-8 (CINC) in the setting of ethanol. Am J Physiol 1995;269:G518-G523.
76. Edwards S, Lalor PF, Nash GB, Rainger GE, Adams DH: Lymphocyte traffic through sinusoidal endothelial cells is regulated by hepatocytes. Hepatology 2005;41:451-459.
77. Alabraba EB, Lai V, Boon L, Wigmore SJ, Adams DH, Afford SC: Coculture of human liver macrophages and cholangiocytes leads to CD40-dependent apoptosis and cytokine secretion. Hepatology 2008;47:552-562.
78. Ahmed-Choudhury J, Russell CL, Randhawa S, et al: Differential induction of nuclear factor-kappaB and activator protein-1 activity after CD40 ligation is as sociated with primary human hepatocyte apoptosis or intrahepatic endothelial cell proliferation. Mol Biol Cell 2003;14:1334-1345.
79. Eksteen B, Miles A, Curbishley SM, et al: Epithelial inflammation is associated with CCL28 production and the recruitment of regulatory T cells expressing CCR10. J Immunol 2006;177:593-603.
80. Matloubian M, David A, Engel S, Ryan JE, Cyster JG: A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo. Nat Immunol 2000;1:298-304.
81. Wilbanks A, Zondlo SC, Murphy K, et al: Expression cloning of the STRL33/BONZO/TYMS TRligand reveals elements of CC, CXC, and CX3C chemokines. J Immunol 2001;166:5145-5154.
82. Heydtmann M, Lalor PF, Eksteen JA, Hubscher SG, Briskin M, Adams DH: CXC chemokine ligand 16 promotesintegrin-mediated adhesion of liver-infiltratingly mphocytes to cholangiocytes and hepatocytes within the inflamed human liver. J Immunol 2005;174:1055-1062.
83. Germanov E, Veinotte L, Cullen R, Chamberlain E, Butcher EC, Johnston B: Critical role for the chemokine receptor CXCR6 in homeostasis and activation of CD1d-restricted NKT cells. J Immunol 2008;181:81-91.
84. Wald O, Pappo O, Safadi R, et al: Involvement of the CXCL12/CXCR4 pathway in the advanced liver disease that is associated with hepatitis C virus or hepatitis B virus. Eur J Immunol 2004;34:1164-1174.
85. Terada R, Yamamoto K, Hakoda T, et al: Stromal cell-derived factor-1 from biliary epithelial cells recruits CXCR4-positive cells: implications for inflammatory liver diseases. Lab Invest 2003;83:665-672.
86. Efsen E, Grappone C, Defranco RM, et al: Up-regulated expression of fractalkine and its receptor CX3CR1 during liver injury in humans. J Hepatol 2002;37:39-47.
87. Isse K, Harada K, Zen Y, et al: Fractalkine and CX3CR1 are involved in the recruitment ofintraepithelial lymphocytes ofintrahepatic bile ducts. Hepatology 2005;41:506-516.
88. Kunkel EJ, Campbell DJ, Butcher EC: Chemokines in lymphocyte trafficking and intestinal immunity. Microcirculation 2003;10:313-323.
89. Pan J, Kunkel EJ, Gosslar U, et al: A novel chemokine ligand for CCR10 and CCR3 expressed by epithelial cells in mucosal tissues. J Immunol 2000;165:2943-2949.
90. Viola A, Luster AD: Chemokines and their receptors: drug targets in immunity and inflammation. Annu Rev Pharmacol Toxicol 2008;48:171-197.
91. Lichterfeld M, Leifeld L, Nischalke HD, et al: Reduced CC chemokine receptor (CCR) 1 and CCR5 surface expression on peripheral blood T lymphocytes from patients with chronic hepatitis C infection. J Infect Dis 2002;185:1803-1807.
92. Nattermann J, Sherzada R, Iwan A, et al: Hepatitis C virus-induced secretion ofinflammatory chemokines preferentially recruits NKG2A(+)CD8(+) T cells. J Infect Dis 2008;198:213-217.
93. Nischalke HD, Nattermann J, Fischer HP, Sauerbruch T, Spengler U, Dumoulin FL: Semiquantitative analysis ofintrahepatic CC-chemokine mRNas in chronic hepatitis C. Mediators Inf lamm 2004;13:357-359.
94. Qin S, Rottman JB, Myers P, et al: The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J Clin Invest 1998;101:746-754.
95. Goddard S, Williams A, Morland C, et al: Differential expression of chemokines and chemokine receptors shapes the inflammatory response in rejecting human liver transplants. Transplantation 2001;72:1957-1967.
96. Murai M, Yoneyama H, Ezaki T, et al: Peyer's patch is the essential site in initiating murine acute and lethal graft-versus-host reaction. Nat Immunol 2003;4:154-160.
97. Moreno C, Gustot T, Nicaise C, et al: CCR5 deficiency exacerbates T-cell-mediated hepatitis in mice. Hepatology 2005;42:854-862.
98. Ajuebor MN, Aspinall AI, Zhou F, et al: Lack of chemokine receptor CCR5 promotes murine fulminant liver failure by preventing the apoptosis of activated CD1d-restricted NKT cells. J Immunol 2005;174:8027-8037.
99. Grant AJ, Goddard S, Ahmed-Choudhury J, et al: Hepatic expression of secondary lymphoid chemokine (CCL21) promotes the development of portal-associated lymphoid tissue in chronic inflammatory liver disease. Am J Pathol 2002;160:1445-1455.
100. Hjelmstrom P, Fjell J, Na kagawa T, Sacca R, Cuff CA, Ruddle NH: Lymphoid tissue homing chemokines are expressed in chronic inflammation. Am J Pathol 2000;156:1133-1138.
101. Bonacchi A, Petrai I, Defranco RM, et al: The chemokine CCL21 modulates lymphocyte recruitment and fibrosis in chronic hepatitis C. Gastroenterology 2003;125:1060-1076.
102. Mondelli MU: Multifaceted functions of B cells in chronic hepatitis C virus infection. Antiviral Res 2003;60:111-115.
103. Faint JM, Annels NE, Curnow SJ, et al: Memory T cells constitute a subset of the human CD8+CD45RA+ pool with distinct phenotypic and migratory characteristics. J Immunol 2001;167:212-220.
104. Förster R, Davalos-Misslitz AC, Rot A: CCR7 and its ligands: balancing immunity and tolerance. Nat Rev Immunol 2008;8:362-371.
105. Schneider MA, Meingassner JG, Lipp M, Moore HD, Rot A: CCR7 is required for the in vivo function of CD4+ CD25+ regulatory T cells. J Exp Med 2007;204:735-745.
106. Bromley SK, Thomas SY, Luster AD: Chemokine receptor CCR7 guides T cell exit from peripheral tissues and entry into afferent lymphatics. Nat Immunol 2005;6:895-901.
107. Briski n M, Winsor-Hines D, Shyjan A, et al: Human mucosal addressin cell adhesion molecule-1 is preferentially expressed in intestinal tract and associated lymphoid tissue. Am J Pathol 1997;151:97-110.
108. Hillan KJ, Hagler KE, MacSween RN, et al: Expression of the mucosal vascular addressin, MAdCAM-1, in inflammatory liver disease. Liver 1999;19:509-518.
109. Grant AJ, Lalor PF, Hubscher SG, Briskin M, Adams DH: MAdCAM-1 expressed in chronic inflammatory liver disease supports mucosal lymphocyte adhesion to hepatic endothelium (MAdCAM-1 in chronic inflammatory liver disease). Hepatology 2001;33:1065-1072.
110. Agace WW: Tissue-tropic effector T cells: generation and targeting opportunities. Nat Rev Immunol 2006;6:682-692.
111. Mora JR, Iwata M, Eksteen B, et al: Generation of gut-homing IgA-secreting B cells by intestinal dendritic cells. Science 2006;314:1157-1160.
112. Eksteen B, Mora JR, Haughton EL, et al: Gut homing receptors on CD8 T-cells are retinoic acid dependent and not maintained by liver dendritic or stellate cells. Gastroenterology 2009;137:320-329.
113. Lee JH, Kang SG, Kim CH: FoxP3+ T cells undergo conventional first switch to lymphoid tissue homing receptors in thymus but accelerated second switch to nonlymphoid tissue homing receptors in secondary lymphoid tissues. J Immunol 2007;178:301-311.
114. Cyster JG: Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs. Annu Rev Immunol 2005;23:127-159.
115. Miyasaka M, Tanaka T: Lymphocyte trafficking across high endothelial venules: dogmas and enigmas. Nat Rev Immunol 2004;4:360-370.
116. von Andrian UH, Mempel TR: Homing and cellular traffic in lymph nodes. Nat Rev Immunol 2003;3:867-878.
117. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M: The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 2004;25:677-686.
118. Adams DH, Harvath L, Bottaro DP, et al: Hepatocyte growth factor and macrophage inflammatory protein 1 beta: structurally distinct cytokines that induce rapid cytoskeletal changes and subset-preferential migration in T cells. Proc Natl Acad Sci USA 1994;91:7144-7148.
119. Hathaway M, Burnett D, Elias E, Adams DH: Secretion of soluble chemotactic factors, including interleukin-6: a mechanism for the recruitment of CD8-positive T lymphocytes to human liver allografts during rejection. Hepatology 1993;18:511-518.
120. Holt AP, Haughton EL, Lalor PF, Filer A, Buckley CD, Adams DH: Liver myofibroblasts regulate infiltration and positioning of lymphocytes in human liver. Gastroenterology 2009;136:705-714.
121. Heydtmann M, Adams DH: Chemokines in the immunopathogenesis of hepatitis C infection. Hepatology 2009;49:676-688.
122. Benseler V, McCaughan GW, Schlitt HJ, Bishop GA, Bowen DG, Bertolino P: The liver: a special case in transplantation tolerance. Semin Liver Dis 2007;27:194-213.
123. Bowen DG, McCaughan GW, Bertolino P: Intrahepatic immunity: a tale of two sites? Trends Immunol 2005;26:512-517.
124. Bowen DG, Zen M, Holz L, Davis T, Mc-Caughan GW, Bertolino P: The site of primary T cell activation is a determinant of the balance between intrahepatic tolerance and immunity. J Clin Invest 2004;114:701-712.
125. Chen W, Jin W, Hardegen N, et al: Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 2003;198:1875-1886.
126. Veldhoen M, Stockinger B: TGFbeta1, a 'Jack of all trades': the link with pro-inf lammatory IL-17-producing T cells. Trends Immunol 2006;27:358-361.
127. Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B: TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006;24:179-189.
128. Wilson NJ, Boniface K, Chan JR, et al: Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol 2007;8:950-957.
129. Costa-Rodriguez EV, Napolitani G, Lanza-vecchia A, Sallusto F: Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation ofinterleukin 17-producing human T helper cells. Nat Immunol 2007;8:942-949.
130. Billerbeck E, Kang YH, Walker L, et al: Analysis of CD161 expression on human CD8+ T cells defines a distinct functional subset with tissue-homing properties. Proc Natl Acad Sci USA 2010;107:3006-3011.
131. Oo YH, Weston CJ, Lalor PF, et al: Distinct roles of CCR4 and CXCR3 in the recruitment and positioning of regulatory T cells in the inflamed human liver. J Immunol 2010;184:2886-2898.